BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kanai T, Kadoya N, Nakajima Y, Miyasaka Y, Ieko Y, Kajikawa T, Ito K, Yamamoto T, Dobashi S, Takeda K, Nemoto K, Jingu K. Evaluation of functionally weighted dose-volume parameters for thoracic stereotactic ablative radiotherapy (SABR) using CT ventilation. Phys Med 2018;49:47-51. [PMID: 29866342 DOI: 10.1016/j.ejmp.2018.05.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Feng A, Shao Y, Wang H, Chen H, Gu H, Duan Y, Gan W, Xu Z. A novel lung-avoidance planning strategy based on 4DCT ventilation imaging and CT density characteristics for stage III non-small-cell lung cancer patients. Strahlenther Onkol 2021. [PMID: 34351454 DOI: 10.1007/s00066-021-01821-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Saha A, Beasley M, Hatton N, Dickinson P, Franks K, Clarke K, Jain P, Teo M, Murray P, Lilley J. Can dosimetry affect local control and survival in patients with early-stage lung cancer treated with Stereotactic Ablative Radiotherapy (SABR)? An analysis of the UK's largest cohort of lung SABR patients. Acta Oncol 2021;60:505-12. [PMID: 33491521 DOI: 10.1080/0284186X.2021.1874617] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Ieko Y, Kadoya N, Kanai T, Nakajima Y, Arai K, Kato T, Ito K, Miyasaka Y, Takeda K, Iwai T, Nemoto K, Jingu K. The impact of 4DCT-ventilation imaging-guided proton therapy on stereotactic body radiotherapy for lung cancer. Radiol Phys Technol 2020;13:230-7. [PMID: 32537735 DOI: 10.1007/s12194-020-00572-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]